Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 5,918
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
Racheal Angom
ID: UNCST-2023-R007485
 Appropriateness, Acceptability, Feasibility, and Usability of an Electronic Medical Records System for Improving Diagnostic Processes and Multidisciplinary Care for Children and Adolescents with Cancer in Uganda: An Implementation Science Approach.
REFNo: HS7249ES

1.Identify barriers and facilitators to EAFYA implementation.
2.Co-design, test, refine, and implement EAFYA-supported diagnostic and MDT pathways.
3.Evaluate implementation success by assessing usability, appropriateness, acceptability, and feasibility.

 Uganda 2026-03-19 16:19:07 2029-03-19 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Dennis Muhanguzi
ID: UNCST-2019-R001101
 Evaluation of The Safety, Efficacy and Stability of SangaDelta® Emulsifiable Concentrate [E.C]: A Randomised Single-Blinded Positive Controlled Multi-Site Acaricide Field Trial
REFNo: NS1194ES

General objectives
To determine the efficacy, safety, and stability of SangaDelta® (Sanga Vet. Chem. Ltd, Kampala Industrial Park, Namanve ) when applied onto cattle by hand spraying and plunge dipping for tick control.

Specific objectives
The specific objectives of this acaricide field trial will to determine:
i.Efficacy of SangaDelta® when applied onto cattle by hand spraying and plunge dipping for tick control.
ii.Safety of SangaDelta® when applied onto cattle by hand spraying and plunge dipping for tick control.
iii.Stability of SangaDelta® when applied onto cattle by plunge dipping for tick control.

Uganda 2026-03-19 16:13:37 2029-03-19 Natural Sciences Clinical Trial Non-degree Award
Jane Frances ABODO
ID: UNCST-2026-R023717
 The 48-Hour Rule on Arraignment of Suspects in Uganda: An Analysis Under International Human Rights Law
REFNo: SS5047ES

(i) To analyze the key differences and similarities between arrest in the laws of Uganda and International Human rights law. (ii) To analyze key differences and similarities between legal representation in the laws of Uganda and international human rights law. (ii) To analyze the key differences between the nature of crime in the laws of Uganda and international human rights law. (iv) To analyze the factors that affect the alignment of the 48-hour rule in the laws of Uganda to international human rights law.
Uganda 2026-03-19 16:09:10 2029-03-19 Social Science and Humanities Non-Clinical Trial Degree Award
Daniel Mwandah Chans
ID: UNCST-2022-R008880
 DEVELOPMENT AND OPTIMIZATION OF ANTIBIOTIC TREATMENT ALGORTHM FOR THE ICU AMID ANTIBIOTIC RESISTANCE: INSIGHTS FROM MBARARA REGIONAL REFERRAL HOSPITAL
REFNo: HS7191ES

4. To develop and validate an antimicrobial optimization tool using biomarkers and antimicrobial Susceptibility data,3. To determine key resistance genes in MDROs from isolates collected among ICU patients in South Western Uganda using PCR.,2. To determine the prevalence, associated factors and patient outcomes among ICU patients with MDROs at ICU of MRRH,1. To conduct a systematic literature review on prevalence, factors associated with, mortality rate, patient outcomes and mechanisms of resistance of MDROs in ICUs in Sub Saharan Africa,The main aim of this proposal is to study MDROs in the ICU of MRRH and optimizing antimicrobial therapy to improve patient outcomes by determining utilization of biomarkers (PCT and CRP) and antibiotic susceptibility tests (ASTs).,
 Uganda 2026-03-19 16:07:23 2029-03-19 Medical and Health Sciences Non-Clinical Trial Degree Award
Adoke Yeka
ID: UNCST-2021-R004300
 A Phase 2A study to evaluate the safety, tolerability and pharmacokinetics of a novel antimalarial pyrrolidinamide at different doses and dose durations, in adult patients with uncomplicated P. falciparum malaria
REFNo: HS7237ES

Primary objective:
To investigate the safety and tolerability of GSK3772701 after single and repeat oral doses in adult patients with uncomplicated P. falciparum malaria.
Secondary objectives
To evaluate the PK profile of single and repeat oral doses of GSK3772701 in adult patients with
uncomplicated P. falciparum malaria.

Exploratory objectives.
1. To evaluate the efficacy of single and repeat oral doses of GSK3772701 in adult patients with uncomplicated P. falciparum malaria.
2. To characterize the PK/PD relationship.
3. To evaluate P. falciparum genetic polymorphisms and potency of GSK3772701.
4. To assess the safety of GSK3772701 for individual parameters after single and repeat oral doses in adult patients with uncomplicated P. falciparum malaria

 Uganda 2026-03-19 16:01:49 2029-03-19 Medical and Health Sciences Clinical Trial Non-degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."

NRIMS